TAKling GDF-15 and skeletal muscle atrophy in pulmonary hypertension: are we there yet?

被引:6
|
作者
Lai, Yen-Chun [1 ]
Provencher, Steeve [2 ]
Goncharova, Elena A. [3 ]
机构
[1] Indiana Univ Sch Med, Dept Med, Div Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46202 USA
[2] Univ Laval, Fac Med, Inst Univ Cardiol & Pneumol, Pulm Hypertens Res Grp,Quebec Res Ctr, Montreal, PQ, Canada
[3] Univ Pittsburgh, Pittsburgh Heart Lung & Blood Vasc Med Inst, Div Pulm Allergy & Crit Care, Pittsburgh, PA USA
关键词
GROWTH-DIFFERENTIATION FACTOR-15; INCREASED EXPRESSION; DYSFUNCTION; RECEPTOR;
D O I
10.1136/thoraxjnl-2018-212680
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:103 / 105
页数:3
相关论文
共 50 条
  • [1] The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH)
    Garfield, Benjamin
    Crosby, Alexi
    Pieran, Yang
    Jen, Lee
    Shao, Dongmin
    Parfitt, Lisa
    Harries, Carl
    Morrell, Nicholas
    Polkey, Michael'
    Kemp, Paul
    Wort, S. John
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [2] Apelin isoforms and GDF-15 are promising biomarkers for pulmonary hypertension
    Foris, V.
    Kovacs, G.
    Tscherner, M.
    Avian, A.
    Olschewski, A.
    Olschewski, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (19-20) : 650 - 650
  • [3] GDF-15 in Follow up in Patients with Idiopathic Pulmonary Arterial Hypertension
    Nickel, N.
    Kempf, T.
    Golpon, H.
    Wollert, K. C.
    Olsson, K.
    deWall, C.
    Welte, T.
    Hoeper, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [4] Dehydroepiandrosterone and GDF-15 for follow-up of patients with pulmonary arterial hypertension
    Foris, Vasile
    Mutgan, Ceren Ayse
    Borenich, Andrea
    Kovacs, Gabor
    Douschan, Philipp
    Sassmannn, Teresa
    Zeder, Katarina
    Olschewski, Andrea
    Kwapiszewska, Grazyna
    Olschewski, Horst
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Growth Differentiation Factor-15 (GDF-15) is Involved in Muscle Atrophy of Patients With Cardiovascular Diseases
    Nakajima, Toshiaki
    Ogawa, Hironaga
    Sawaguchi, Tatsuya
    Obi, Syotarou
    Ikuko, Shibasaki
    Takei, Yuusuke
    Sakuma, Satoshi
    Toyoda, Shigeru
    Nishimura, Masao
    Fukuda, Hirotsugu
    Inoue, Teruo
    CIRCULATION, 2019, 140
  • [6] GDF-15 in Pulmonary and Critical Care Medicine
    Verhamme, Fien M.
    Freeman, Christine M.
    Brusselle, Guy G.
    Bracke, Ken R.
    Curtis, Jeffrey L.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 60 (06) : 621 - 628
  • [7] Does Hemodialysis Weaken GDF-15 Impairing Pulmonary Hypertension in Chronic Kidney Failure?
    Tang Yifang
    Zhou Zhu
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension
    Keranov, Stanislav
    Widmann, Laila
    Jafari, Leili
    Liebetrau, Christoph
    Keller, Till
    Troidl, Christian
    Kriechbaum, Steffen
    Voss, Sandra
    Bauer, Pascal
    Richter, Manuel J.
    Tello, Khodr
    Gall, Henning
    Ghofrani, Hossein A.
    Wiedenroth, Christoph B.
    Guth, Stefan
    Seeger, Werner
    Hamm, Christian W.
    Nef, Holger
    Dorr, Oliver
    BIOMARKERS IN MEDICINE, 2022, 16 (17) : 1193 - 1207
  • [9] Correlation between serum GDF-15 level and pulmonary vascular morphological changes and prognosis in patients with pulmonary arterial hypertension
    Maimaiti, Yasenjiang
    Cheng, Hui
    Guo, Zitong
    Yu, Xiaolin
    Tuohuti, Adilijiang
    Li, Guoqing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [10] Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Lv, Zhigan
    Liang, Guohua
    Cheng, Mengyu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2431 - 2438